The ASX is lower by around 0.6% on Thursday at 1pm AEDT, with the energy sector in particular feeling the heat and dragging ...
Mesoblast, a regenerative medicines developer with a market capitalization of $3.1 billion, is set to be included in the ...
In today’s news, APRA’s new rules target bank and super boards, the Gold Coast records its “highest ever” wave as Cyclone Alfred barrels in, and Donald Trump sets off a chain reaction across global ...
Shares lower, oil price slump hits Santos, Woodside; Greg Foran resigns as Air NZ CEO; Myer rallies; Amcor hints at exec ...
These shares are falling more than most on Thursday. But why? The post Why Appen, Mesoblast, Rio Tinto, and Woodside shares ...
Mesoblast shares fell by more than 5% in morning trade after the dual-listed biotech company was added to the ASX 200 index.
This biotech has been on fire but the gains may not be over yet according to Bell Potter. The post Why Mesoblast shares could still be dirt cheap even after 700% gain appeared first on The Motley Fool ...
The ASX took a hit on Thursday, with the energy sector sinking. Meanwhile gold miners shone and Star casino was handed a ...